Find Clinical Trials

Advanced Search

Study phase

Document

Therapeutic area group

Indication

SEARCH CLEAR

185 Results

Protocol Code Study Title Active substance/Medical device Study Phase Therapeutic Area
CL1-95014-001 A Phase 2 Clinical Study of Pegaspargase in Patients With Newly Diagnosed, Untreated Acute Lymphoblastic… PEGASPARGASE,
S095014 		Phase 2 Cancers
CL1-64315-003 A Phase I/II, open label, non-randomized study to evaluate safety, tolerability, pharmacokinetics and clinical activity… S064315 Phase 1-2 Cancers
CL3-13001-002 Clinical Investigation to Determine the Accuracy and Benefit of Cardioskin™ in Patients With Known Atrial… Cardioskin™ Phase 3 Cardiovascular Diseases
331602 Post Marketing Surveillance Study for ONIVYDE® in South Korea Liposomal Irinotecan,
S095013 		Phase 4 Cancers
331501 Phase II Randomized Study of BAX2398 in Combination With 5-Fluorouracil and Calcium Levofolinate in Japanese… Liposomal Irinotecan,
S095013 		Phase 2 Cancers
CL1-65487-002 Study of a New Intravenous Drug, Called S065487, in Patients With Acute Myeloid Leukemia, Non… S065487 Phase 1 Cancers
CL1-64315-002 An International Phase Ib Multicentre Study to Characterize the Safety and Tolerability of Intravenously Administered… S064315 Phase 1 Cancers
CL3-95008-002 Efficacy and safety of bumetanide oral liquid formulation in children aged from 2 to less… BUMETANIDE,
S095008 		Phase 3 Neuropsychiatric Diseases
CL3-95008-001 Efficacy and safety of bumetanide oral liquid formulation in children and adolescents aged from 7… BUMETANIDE,
S095008 		Phase 3 Neuropsychiatric Diseases
CL2-201086-002 Efficacy and safety of 3 doses of S201086/GLPG1972 administered orally once daily in patients with… S201086 Phase 2 Rheumatology
Control-2 Efficacy of ivabradine in combination with beta-blockers vs up-titration of beta-blockers in daily practice IVABRADINE,
S016257 		Phase 4 Cardiovascular Diseases
CL3-05153-008 A clinical study to test the safety and the efficacy of a single-pill combination of… AMLODIPINE, ATORVASTATIN, PERINDOPRIL ARGININE,
S005153 		Phase 3 Cardiovascular Diseases
CL3-05682-109 Clinical non-inferiority study between Micronized purified flavonoid fraction 1000 mg, one chewable tablet per day… MICRONISED PURIFIED FLAVONOID FRACTION,
S005682 		Phase 3 Cardiovascular Diseases
CL1-95010-001 Safety, Tolerability and Pharmacokinetics of S 95010 After Single Escalating Intravenous Doses in Young Healthy… S095010 Phase 1 Cardiovascular Diseases
CL3-95005-006 An open-label, randomised, phase III Study cOmparing trifLuridine/tipiracil (S 95005) in combination with bevacizumab to… TIPIRACIL, TRIFLURIDINE,
S095005 		Phase 3 Cancers
CL1-81694-003 Phase I/II trial of S 81694 administered intravenously in combination with paclitaxel to evaluate the… S081694 Phase 1-2 Cancers
CL1-49076-002 Phase I/II study of S49076, a multi-target inhibitor of c-MET, AXL, FGFR in combination with… S049076 Phase 1-2 Cancers
CL1-80881-002 INES - Phase Ib dose allocation study of oral administration of lucitanib given in combination… LUCITANIB,
S080881 		Phase 1 Cancers
CL1-68587-001 A phase 1, open label, non-comparative, monocenter study to evaluate the safety and the ability… UCART19,
S068587 		Phase 1 Cancers
IC4-95005-183-DEU Prospective, Multicenter, Open-label Phase IV trial of Trifluridine/Tipiracil to Evaluate the Health-related Quality of Life… TIPIRACIL, TRIFLURIDINE,
S095005 		Phase 4 Cancers
SC3-90049-001 Assessment of the acceptability of a sublingual formulation of piribedil (S90049), 10 to 30 mg… PIRIBEDIL,
S090049 		Phase 3 Neuropsychiatric Diseases
SC2-90049-003 Effect of 3 doses (20, 40 and 60 mg) of a sublingual formulation of piribedil… PIRIBEDIL,
S090049 		Phase 2 Neuropsychiatric Diseases
PKH-05720-001 A study to assess the release profiles from fixed combination tablets (gliclazide MR/metformin) GLICLAZIDE, METFORMINE,
S005720 		Phase 1 Metabolism
MC3-06790-001 Study of the effect of trimetazidine MR 35 mg (2 tabs/day) on the emergence of… TRIMETAZIDINE,
S006790 		Phase 3 Other
IC4-5702-205-CHN Study of Combination Therapy of Gliclazide MR and Basal Insulin Versus Insulin Monotherapy to Treat… GLICLAZIDE,
S005702 		Phase 4 Metabolism

Servier clinical trials are mainly registered on


EU Clinical Trials Register

The EU Clinical Trials Register contains information on interventional clinical trials on medicines conducted in Europe, which started after 1 May 2004.

SEE MORE

ClinicalTrials.gov

Clinicaltrials.gov is a registry and results database of publicly and privately supported clinical studies of human participants conducted around the world.

SEE MORE

ISRCTN registry

The ISRCTN registry is a primary clinical trial registry recognised by WHO and ICMJE that accepts all clinical research studies.

SEE MORE
© 2017 LES LABORATOIRES SERVIER, an incorporated company of Servier.
All Rights Reserved. Servier does not sell its products over the Internet.
More information

Report a side-effect with a drug.
Accessibility